Open AccessLow‐dose niacin supplementation modulates GPR109A, niacin index and ameliorates Parkinson's disease symptoms without side effects
Author(s) -
Wakade Chandramohan,
Chong Raymond,
Bradley Eric,
Morgan John C.
Publication year - 2015
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.232
Subject(s) - niacin , medicine , gastroenterology , pittsburgh sleep quality index , pharmacology , anesthesia , sleep quality , insomnia
Key Clinical Message A 65‐year‐old male, Parkinson's disease patient, was evaluated for GPR 109A expression, niacin index, UPDRS scale, handwriting test, and quality of sleep with and without niacin treatment. The evaluation was repeated 3 months after niacin was stopped. Niacin modulated the abovementioned parameters and showed the overall improvement without side effects.